Letroza, 30 tablets

Letroza (Letrozole)

Dosage form:

Tablets, film-coated, 2,5 mg.

Registration number:

ЛСР-008891/09-221210

Indications for use

Adjuvant therapy for early-stage breast cancer in postmenopausal women.

As extended adjuvant therapy after standard adjuvant Tamoxifen therapy for early-stage breast cancer in postmenopausal women.

First line therapy for:

  • Common forms of hormone-dependent breast cancer in postmenopausal women.
  • Common forms of breast cancer in postmenopausal women ( natural or induced ) treated prior anti-estrogen therapy.
RUS

Ask the expert Anstar AG